Valuation: AstraZeneca PLC

Market Cap 295B 259B 239B 221B 419B 28,262B 427B 2,873B 1,116B 13,830B 1,108B 1,084B 48,011B P/E 2026 *
23.8x
P/E 2027 * 20.9x
Enterprise Value 314B 276B 255B 235B 446B 30,112B 455B 3,061B 1,189B 14,736B 1,181B 1,155B 51,153B EV / Sales 2026 *
4.98x
EV / Sales 2027 * 4.59x
Free-Float
96.63%
Yield 2026 *
1.75%
Yield 2027 * 1.85%

Last Transcript: AstraZeneca PLC

1 day-9.28%
1 week-10.95%
Current month-8.18%
1 month-5.03%
3 months-15.25%
6 months-8.93%
Current year-6.12%
1 week 12,738
Extreme 12738
14,566
1 month 11,484
Extreme 11484
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,178
Extreme 10178
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
Jun. 07Free

See Remarks

1 0.0000%
May. 19Sell

See Remarks

-11,893 0.0008%
May. 13Fiscal year

Chief Executive Officer

18,359 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-9.23%-10.95%+24.94%+27.17% 295B
-1.60%+2.02%+56.34%+168.94% 1,084B
-1.44%+3.71%+69.07%+65.40% 634B
-0.75%+0.67%+33.18%+86.52% 447B
-0.39%-2.23%+28.42%+25.88% 330B
-0.60%-2.08%+28.51%+46.14% 285B
-1.04%-3.54%-27.72%-39.68% 218B
-0.03%+1.84%+23.90%+68.30% 199B
-0.40%+7.82%+22.29%+82.50% 169B
-0.08%+0.71%-6.13%-32.31% 137B
Average -1.04%+2.34%+25.28%+49.89% 379.69B
Weighted average by Cap. -0.49%+2.42%+38.50%+80.95%

Financials

2026 *2027 *
Net sales 63.19B 55.42B 51.17B 47.28B 89.62B 6,050B 91.41B 615B 239B 2,961B 237B 232B 10,278B 66.84B 58.63B 54.12B 50.02B 94.8B 6,400B 96.7B 651B 253B 3,132B 251B 246B 10,872B
Net income 12.45B 10.92B 10.08B 9.32B 17.66B 1,192B 18.01B 121B 47.1B 583B 46.76B 45.74B 2,025B 13.96B 12.25B 11.3B 10.45B 19.8B 1,337B 20.2B 136B 52.81B 654B 52.43B 51.28B 2,271B
Net Debt 19.32B 16.94B 15.64B 14.46B 27.4B 1,850B 27.95B 188B 73.07B 905B 72.55B 70.96B 3,142B 11.81B 10.36B 9.56B 8.84B 16.75B 1,131B 17.08B 115B 44.66B 553B 44.34B 43.37B 1,921B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-09 GBX 12,924.00 -9.24% 2,418,577
26-07-08 GBX 14,240.00 -0.86% 1,480,149
26-07-07 GBX 14,364.00 +1.87% 1,528,247
26-07-06 GBX 14,100.00 -2.46% 2,008,204
26-07-03 GBX 14,456.00 -0.56% 653,264
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
190.30USD
Average target price
217.14USD
Spread / Average Target
+14.10%

Quarterly revenue - Rate of surprise